Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Novel PDE IV inhibitors in the pipeline at Jouveinal/Parke-Davis

April 8, 1998

RPR-130737, a potent nonpeptidyl inhibitor of factor Xa

April 7, 1998

Merck & Co. designates thrombin inhibitor for clinical development

April 7, 1998

Pfizer NK1 antagonist and ondansetron provide synergistic antiemetic efficacy in clinical trials

April 7, 1998

Early clinical trial evaluates orbofiban pharmacodynamics

April 7, 1998

First clinical trials performed with BMS-181885

April 7, 1998

Phase Ib results reported for allosteric Hb modifier RSR13

April 7, 1998

Novel antisecretory/antiulcer agent from Shionogi undergoes evaluation in Japan

April 7, 1998

YM-905 shows promising activity in animal model of IBS

April 6, 1998

YM-905 shows promise as safe and effective treatment for overactive detrusor

April 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...